Pulmonary hypertension in systemic lupus erythematosus: Prevalence, predictors and diagnostic strategy

Autoimmunity Reviews

Volumn 12, Issue 3, 2013, Pages 410-415

  Ruiz Irastorza, Guillermo ^a   Garmendia, Maider ^a   Villar, Irama ^a   Egurbide, Maria Victoria ^a   Aguirre, Ciriaco ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

Anti RNP; Antiphospholipid; Damage; Lupus activity; MPAP; NPV; PAD; PAH; PAP; PH; PPV; Pulmonary arterial hypertension; Raynaud's; RVSP; S; SD; SDI; SLE; SLEDA; SP; TJV

Indexed keywords

ADULT; CROSS-SECTIONAL STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; HEART CATHETERIZATION; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PREVALENCE; PULMONARY HYPERTENSION; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; YOUNG ADULT;

EID: 84872381980     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.07.010     Document Type: Review

References (37)

1. Badesch D.B., Champion H.C., Gomez Sanchez M.A., Hoeper M.M., Loyd J.E., Manes A., et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009, 54(Suppl. S):55-66.
2. McLaughlin V.V., Archer S.L., Badesch D.B., Barst R.J., Farber H.W., Lindner J.R., et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009, 119:2250-2294.
3. Galiè N., Hoeper M.M., Humbert M., Torbicki A., Vachiery J.-L., Barbera J.A., et al. ESC Committee for Practice Guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009, 30:2493-2537.
4. Thenappan T., Shah S.J., Rich S., Gomberg-Maltland M. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J 2007, 30:1103-1110.
5. Hassoun P.M. Pulmonary arterial hypertension complicating connective tissue diseases. Semin Respir Crit Care Med 2009, 30:429-439.
6. Li E.K., Tam L.S. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients. J Rheumatol 1999, 26:1923-1929.
7. Cervera R., Khamashta A., Font J., Sebastiani G.D., Gil A., Lavilla P., et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003, 82:299-308.
8. Asherson R.A., Hackett D., Gharavi A.E., Harris E.N., Kennedy H.G., Hughes G.R.V. Pulmonary hypertension in systemic lupus erythematosus: a report of three cases. J Rheumatol 1986, 13:416-420.
9. Simonson J.S., Schiller N.B., Petri M., Hellman D.B. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989, 16:918-925.
10. Kasparian A., Floros A., Gialafos E., Kanakis M., Tassiopoulos S., Kafasi N., et al. Raynaud's phenomenon is correlated with elevated systolic pulmonary arterial pressure in patients with systemic lupus erythematosus. Lupus 2007, 16:505-508.
11. Asherson R.A., Higenbottam T.W. Dinh Xuan AT, Khamashta MA, Hughes GR. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 1990, 17:1292-1298.
12. Farzaneh-Far A., Roman M.J., Lockshin M.D., Devereux R.B., Paget S.A., Crow M.K., et al. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Arthritis Rheum 2006, 54:3918-3925.
13. Nishimaki T., Aotsuka S., Kondo H., Yamamoto K., Takasaki Y., Sumiya M., et al. Immunological analysis of pulmonary hypertension in connective tissue diseases. J Rheumatol 1999, 26:2357-2362.
14. Shen J.Y., Chen S.L., Wu Y.X., Tao R.Q., Gu Y.Y., Bao C.D., et al. Pulmonary hypertension in systemic lupus erythematosus. Rheumatol Int 1999, 18:147-151.
15. Cefle A., Inanc M., Sayarlioglu M., Kamali S., Gul A., Ocal L., et al. Pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid and severe disease outcome. Rheumatol Int 2009, 30:253-258.
16. Winslow T.M., Ossipov M.A., Fazio G.P., Simonson J.S., Redberg R.F., Schiller N.B. Five year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J 1995, 129:510-515.
17. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum 1997, 40:1725.
18. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996, 39:363-369.
19. Gladman D.D., Ibañez D., Urowitz M.B. SLE disease activity index 2000. J Rheumatol 2002, 29:288-291.
20. Pope J. An update in pulmonary hypertension in systemic lupus erythematosus - do we need to know about it?. Lupus 2008, 17:274-277.
21. Fisher M.R., Forfia P.R., Chamera E., Housten-Harris T., Champion H.C., Girgis R.E., et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 2009, 179:615-621.
22. Perez H.D., Kramer N. Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature. Semin Arthritis Rheum 1981, 11:177-181.
23. Badui E., García-Rubi D., Robles E., Jimenez J., Juan L., Deleze M., et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985, 36:431-441.
24. Ling-Te Pan T., Thumboo J., Boey M.L. Primary and secondary pulmonary hypertension in systemic lupus erythematosus. Lupus 2000, 9:338-342.
25. Tanaka E., Harigai M., Tanaka M., Kawaguchi Y., Hara M., Kamatani N. Pulmonary hypertension in systemic lupus erythematosus: evaluation of clinical characteristics and response to immunosuppressive treatment. J Rheumatol 2002, 29:282-287.
26. Johnson S.R., Gladman D.D., Urowitz M.B., Ibañez D., Granton J.T. Pulmonary hypertension in systemic lupus. Lupus 2004, 13:506-509.
27. Prabu A., Patel K., Yee C.S., Nightingale P., Situnayake R.D., Thickett D.R., et al. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford) 2009, 48:1506-1511.
28. Quadrelli S.A., Alvarez C., Arce S.C., Paz L., Sarano J., Sobrino E.M., et al. Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies. Lupus 2009, 18:1053-1060.
29. Foïs E., Le Guern V., Dupuy A., Humbert M., Mouthon L., Guillevin L. Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. Clin Exp Rheumatol 2010, 28:836-841.
30. Kamel S.R., Omar G.M., Darwish A.F., Asklany H.T., Ellabban A.S. Asymptomatic pulmonary hypertension in systemic lupus erythematosus. Clin Med Insights Arthritis Musculoskelet Disord 2011, 4:77-86.
31. Bourre-Tessier J., Huynh T., Clarke A.E., Bernatsky S., Joseph L., Belisle P., et al. Features associated with cardiac abnormalities in systemic lupus erythematosus. Lupus 2011, 20:1518-1525.
32. Chow S.L., Chandran V., Fazelzad R., Johnson S.R. Prognostic factors for survival in systemic lupus erythematosus associated pulmonary hypertension. Lupus 2012, 21:353-364.
33. Jaïs X., Launay D., Yaici A., Le Pavec J., Tchérakian C., Sitbon O., et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum 2008, 58:521-531.
34. Kato M., Kataoka H., Odani T., Fujieda Y., Otomo K., Oku K., et al. The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review. Lupus 2011, 20:1047-1056.
35. Condliffe R., Kiely D.G., Peacock A.J., Corris P.A., Gibbs J.S.R., Vrapi F., et al. Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009, 179:151-157.
36. Almeida I., Faria R., Vita P., Vasconcelos C. Systemic sclerosis refractory disease: from the skin to the heart. Autoimmun Rev 2011, 10:693-701.
37. Dimitroulas T., Giannakoulas G., Karvounis H., Garyfallos A., Settas L., Kitas G. B-type natriuretic peptide in rheumatic diseases: a cardiac biomarker or a sophisticated acute phase reactant?. Autoimmun Rev 2012, [Epub ahead of print].